Skip to content
Life Sciences Series B Founded 2018

Refeyn

Developer of a technology for the measurement of single molecular mass

📍 Oxford, United Kingdom · Life Sciences Platforms and Tools

Funding snapshot

Last roundSeries B
Amount$33M
Date5 April 2022

About

Refeyn develops technology for the measurement of single molecular mass. The company's product includes Refyn (mass photometry) that uses single-molecule light scattering for the detection of molecular properties of biomolecules.

Latest news

No articles yet.

Raising like Refeyn?

Analyze your pitch deck before your next raise.

Analyze My Deck →